Actions

CD14: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
 
(18 intermediate revisions by the same user not shown)
Line 17: Line 17:
<span style="color:navy">'''Normal expression and function'''</span>
<span style="color:navy">'''Normal expression and function'''</span>


xxxxx
Together with co-receptors cell surface, CD14 binds the bacterial cell wall component lipopolysaccharide (LPS) helping initiate cytokine secretion and the inflammatory response when bacteria are detected. CD14 is expressed mainly by monocytes dendritic cells and macrophages and to a much lower extent by neutrophils. CD14 is weakly expressed or absent on early monocytes, but expression becomes progressively stronger as the cells mature. 




Line 23: Line 23:
<span style="color:navy">'''Diagnostic role'''</span>  
<span style="color:navy">'''Diagnostic role'''</span>  


*xxxxx
*CD14 is a useful marker of monocytic lineage in aml
 
*CD14 may be absent on less mature monoblasts, while in myelomonocytic lineage cells will express CD14 on the monocytic population of blasts
 
*In cmml expression of CD14 is expected, so it does not distinguish cmml and monocytic aml
 
*Expression is very uncommon on lymphoid lineage 
 




Line 30: Line 37:
<span style="color:navy">'''Other relevant information:'''</span>  
<span style="color:navy">'''Other relevant information:'''</span>  


xxxxx
CD14 is glycophosphoinositol gpi linked and will therefore be absent in cells affected by paraxysmol nocturnal haemoglobinuria (PNH)




Line 36: Line 43:


<span style="color:navy">'''''SUMMARY TABLES'''''</span>
<span style="color:navy">'''''SUMMARY TABLES'''''</span>
<span style="font-size:90%">'''Note''' The colour and % refer to the proportion of cases expressing the marker. Additional comments on strength, or site of expression (if relevant) are given below the table. For full details of key click [[Key to marker expression table|here]]. For further information about a particular disease state click <<span style="color:blue>'''I'''</span>> adjacent to the condition name</span>
{| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
|-
!colspan="8"|'''Expression in primitive cell types'''</font>
|- <span style="font-size:70%">
!AML!!CMML !!B ALL !!BL ||T ALL !!ETP ALL !!MPAL ||Hgn</span>
|-<span style="font-size:70%">
|style="width: 12.5%; background: #66e0ff; color:black"|20-40%
|style="width: 12.5%; background: #004466; color:white"|80-100%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|-
|}
<span style="font-size:90%">'''Notes:''' In aml CD14 expression defines monocytic lineage restriction but may be absent especially in more primitive monoblastic cases  </span>
{| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;"
|-
!colspan="8"|'''Expression in mature B cell neoplasms'''
|- <span style="font-size:70%">
! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL || LPL !! PCL
|-<span style="font-size:70%">
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|style="width: 12.5%; background: #E6FAFF; color:black"|<5%
|-
|}
<span style="font-size:90%">'''Notes:''' Low level expression has been reported on activated lymphocytes, but it has no definite diagnostic role </span>
{| class=wikitable style="text-align: center; font-size:80%; width: 62.4%; height 40px;"
|-
!colspan="7"|'''Expression in mature T cell neoplasms'''
|-
! ATLL !! CTCL/Sezary !! T-PLL !! T-LGL !! NK-LGL
|-
|style="width: 14.25%; background: #E6FAFF; color:black"|<5%
|style="width: 14.25%; background: #E6FAFF; color:black"|<5%
|style="width: 14.25%; background: #E6FAFF; color:black"|<5%
|style="width: 14.25%; background: #E6FAFF; color:black"|<5%
|style="width: 14.25%; background: #E6FAFF; color:black"|<5%
|-
|}
----

Latest revision as of 21:38, 4 July 2023


Summary
CD14 aids recognition of bacteria by cells of monocytic lineage, it is regarded as a pan-monocyte antigen. Expression of CD14 is not restricted to malignant cells as it is also expressed by normal and reactive monocytes
when expressed in aml CD14 is a marker of monocytic lineage, but absence of CD14 expression does not preclude monocytic lineage in AML and CMML since some typical monoblasts may not express this marker



Normal expression and function

Together with co-receptors cell surface, CD14 binds the bacterial cell wall component lipopolysaccharide (LPS) helping initiate cytokine secretion and the inflammatory response when bacteria are detected. CD14 is expressed mainly by monocytes dendritic cells and macrophages and to a much lower extent by neutrophils. CD14 is weakly expressed or absent on early monocytes, but expression becomes progressively stronger as the cells mature.


Diagnostic role

  • CD14 is a useful marker of monocytic lineage in aml
  • CD14 may be absent on less mature monoblasts, while in myelomonocytic lineage cells will express CD14 on the monocytic population of blasts
  • In cmml expression of CD14 is expected, so it does not distinguish cmml and monocytic aml
  • Expression is very uncommon on lymphoid lineage



Other relevant information:

CD14 is glycophosphoinositol gpi linked and will therefore be absent in cells affected by paraxysmol nocturnal haemoglobinuria (PNH)



SUMMARY TABLES


Note The colour and % refer to the proportion of cases expressing the marker. Additional comments on strength, or site of expression (if relevant) are given below the table. For full details of key click here. For further information about a particular disease state click <I> adjacent to the condition name


Expression in primitive cell types
AML CMML B ALL BL T ALL ETP ALL MPAL Hgn
20-40% 80-100% <5% <5% <5% <5% <5% <5%

Notes: In aml CD14 expression defines monocytic lineage restriction but may be absent especially in more primitive monoblastic cases


Expression in mature B cell neoplasms
CLL MCL FL MZL HCL DLBCL LPL PCL
<5% <5% <5% <5% <5% <5% <5% <5%

Notes: Low level expression has been reported on activated lymphocytes, but it has no definite diagnostic role


Expression in mature T cell neoplasms
ATLL CTCL/Sezary T-PLL T-LGL NK-LGL
<5% <5% <5% <5% <5%